{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:51:09Z","timestamp":1770965469930,"version":"3.50.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1983,9,1]],"date-time":"1983-09-01T00:00:00Z","timestamp":431222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1983,9]]},"DOI":"10.1007\/bf01296907","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T23:44:26Z","timestamp":1111707866000},"page":"833-842","source":"Crossref","is-referenced-by-count":196,"title":["Sulfasalazine"],"prefix":"10.1007","volume":"28","author":[{"given":"Sanford L.","family":"Taffet","sequence":"first","affiliation":[]},{"given":"Kiron M.","family":"Das","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.0954-6820.1942.tb06841.x","volume":"110","author":"N Svartz","year":"1942","unstructured":"Svartz N: Salazopyrin, a new sulfonilamide preparation. Acta Med Scand 110:557?598, 1942","journal-title":"Acta Med Scand"},{"issue":"Suppl","key":"CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.0954-6820.1948.tb12083.x","volume":"206","author":"N Svartz","year":"1948","unstructured":"Svartz N: The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts at desensibilization in cases of hypersensitiveness to sulfa. Acta Med Scand (Suppl) 206:465?472, 1948","journal-title":"Acta Med Scand"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0049-0172(82)90060-9","volume":"12","author":"JS Dixon","year":"1982","unstructured":"Dixon JS: Biochemical and clinical changes in rheumatoid arthritis: Their relation to the action of antirheumatoid drugs. Semin Arthritis Rheum 12:191?207, 1982","journal-title":"Semin Arthritis Rheum"},{"key":"CR4","first-page":"36","volume":"9","author":"HA Bird","year":"1982","unstructured":"Bird HA, Dixon JS, Pickup ME, Rhind VM, Lowe JR, Lee MR, Wright V: A biochemical assessment of sulphasalazine in rheumatoid arthritis. J Rheumatol 9:36?45, 1982","journal-title":"J Rheumatol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0016-5085(19)33139-7","volume":"65","author":"P Goldman","year":"1973","unstructured":"Goldman P, Peppercorn MA: Salicylazosulfapyridine in clinical practice. Gastroenterology 65:166?169, 1973","journal-title":"Gastroenterology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM197507032930105","volume":"293","author":"P Goldman","year":"1975","unstructured":"Goldman P, Peppercorn MA: Sulfasalazine. N Engl Med 293:20?23, 1975","journal-title":"N Engl Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(62)92080-9","volume":"1","author":"JH Baron","year":"1962","unstructured":"Baron JH, Connell AM, Lennard-Jones JE, Jones FA: Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet 1:1094?1096, 1962","journal-title":"Lancet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.5.5.437","volume":"5","author":"AP Dick","year":"1964","unstructured":"Dick AP, Grayson MJ, Carpenter RG, Petrie A: Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 5:437?442, 1964","journal-title":"Gut"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(65)90972-4","volume":"1","author":"JJ Misiewicz","year":"1965","unstructured":"Misiewicz JJ, Lennard-Jones JE, Connell AM, Parson JH, Avery Jones F: Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet 1:185?188, 1965","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.14.12.923","volume":"14","author":"AS Dissanayake","year":"1973","unstructured":"Dissanayake AS, Truelove SC: A controlled therapeutic trial of long term maintenance therapy for ulcerative colitis with sulphasalazine (Salazopyrin). Gut 14:923?926, 1973","journal-title":"Gut"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/00365521.1974.12096873","volume":"9","author":"P Anthonisen","year":"1974","unstructured":"Anthonisen P, Barany F, Folkenburg O, Holtz S, Janum S, Kristensen M, Rios P, Walen A, Worning H: The clinical effect of salazosulphapyridine (Salazopyrin) in Crohn's disease. A controlled double-blind study. Scand J Gastroenterol 9:549?554, 1974","journal-title":"Scand J Gastroenterol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.14.8.631","volume":"14","author":"KM Das","year":"1973","unstructured":"Das KM, Eastwood MA, McManus JPA, Sircus W: The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and response to treatment in inpatients. II. The relationship between metabolism and progress of the disease studied in outpatients. Gut 14:631?641, 1973","journal-title":"Gut"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/00365521.1974.12096805","volume":"9","author":"KM Das","year":"1974","unstructured":"Das KM, Eastwood MA, McManus JPA, Sircus W: The role of the colon in the metabolism of salicylazosulphapyridine. Scand J Gastroenterol 9:137?141, 1974","journal-title":"Scand J Gastroenterol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0016-5085(73)80035-6","volume":"64","author":"MA Peppercorn","year":"1973","unstructured":"Peppercorn MA, Goldman P: Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 64:240?245, 1973","journal-title":"Gastroenterology"},{"key":"CR15","first-page":"555","volume":"181","author":"MA Peppercorn","year":"1972","unstructured":"Peppercorn MA, Goldman P: The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther 181:555?562, 1972","journal-title":"J Pharmacol Exp Ther"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(77)90831-5","volume":"2","author":"AK Azad Khan","year":"1977","unstructured":"Azad Khan AK, Piris J, Truelove SC: An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2:892?895, 1977","journal-title":"Lancet"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/gut.21.7.632","volume":"21","author":"PAM Hees Van","year":"1980","unstructured":"Van Hees PAM, Bakker JH, Van Tongeren JHM: Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis. A study to determine the active therapeutic moiety of sulphasalazine. Gut 21:632?635, 1980","journal-title":"Gut"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00007611-196804000-00005","volume":"61","author":"JR Collins","year":"1968","unstructured":"Collins JR: Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis. South Med J 61:354?358, 1968","journal-title":"South Med J"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM197309062891001","volume":"289","author":"KM Das","year":"1973","unstructured":"Das KM, Eastwood MA, McManus JPA, Sircus W: Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 289:491?495, 1973","journal-title":"N Engl J Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9343(82)90330-8","volume":"73","author":"SL Taffet","year":"1982","unstructured":"Taffet SL, Das KM: Desensitization of patients with inflammatory bowel disease to sulfasalazine. Am J Med 73:520?524, 1982","journal-title":"Am J Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cpt1975185part1514","volume":"18","author":"KM Das","year":"1975","unstructured":"Das KM, Eastwood MA: Acetylation polymorphism of sulphapyridine in patients with ulcerative colitis and Crohn's disease. Clin Pharmacol Ther 18:514?520, 1975","journal-title":"Clin Pharmacol Ther"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2165\/00003088-197601060-00002","volume":"1","author":"KM Das","year":"1976","unstructured":"Das KM, Dubin R: Clinical pharmacokinetics of sulphasalazine. Clin Pharmacokinet 1:406?425, 1976","journal-title":"Clin Pharmacokinet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/gut.21.3.232","volume":"21","author":"AK Azad Khan","year":"1980","unstructured":"Azad Khan AK, Howes DT, Piris J, Truelove SC: Optimum dose of sulphasalazine for maintenance treatment of ulcerative colitis. Gut 21:232?240, 1980","journal-title":"Gut"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0016-5085(79)90386-X","volume":"77","author":"JW Singleton","year":"1979","unstructured":"Singleton JW, Law DH, Kelley ML, Mekhjian HS, Sturdevant RAL: National Cooperative Crohn's Disease Study: Adverse reactions to study drugs. Gastroenterology 77:870?882, 1979","journal-title":"Gastroenterology"},{"key":"CR25","first-page":"545","volume":"55","author":"K Jamshidi","year":"1972","unstructured":"Jamshidi K, Arlander T, Garcia, MC, Windschith HW, Swaim WR: Azulfidine agranulocytosis with bone marrowmegakaryocytosis, histiocytosis, plasmacytosis. Minn Med 55:545?548, 1972","journal-title":"Minn Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(58)92005-1","volume":"1","author":"AI Spriggs","year":"1958","unstructured":"Spriggs AI, Smith RS, Griffith H, Truelove, SC: Heinzbody anemia due to salicylazosulphapyridine. Lancet 1:1039?1042, 1958","journal-title":"Lancet"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/gut.16.3.181","volume":"16","author":"RE Pounder","year":"1975","unstructured":"Pounder RE, Craven ER, Henthorn JS, Bannatyne JM: Red cells abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. Gut 16:181?185, 1975","journal-title":"Gut"},{"key":"CR28","first-page":"1372","volume":"289","author":"EP Gabor","year":"1973","unstructured":"Gabor EP: Hemolytic anemia as adverse reaction to salicylazosulfapyridine. N Engl J Med 289:1372, 1973","journal-title":"N Engl J Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-97-5-726","volume":"97","author":"KR Wheelan","year":"1982","unstructured":"Wheelan KR, Cooper B, Stone MJ: Multiple hematologic abnormalities associated with sulfasalazine. Ann Intern Med 97:726?727, 1982","journal-title":"Ann Intern Med"},{"issue":"6080","key":"CR30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/bmj.2.6080.190-a","volume":"2","author":"M Bateson","year":"1977","unstructured":"Bateson M: Megaloblastic anaemia associated with sulphasalazine treatment. Br Med J 2(6080):190, 1977","journal-title":"Br Med J"},{"issue":"6097","key":"CR31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bmj.2.6097.1287-a","volume":"2","author":"S Kane","year":"1977","unstructured":"Kane S, Boots MA: Megaloblastic anaemia associated with sulphasalazine treatment. Br Med J 2(6097):1287?1288, 1977","journal-title":"Br Med J"},{"issue":"6077","key":"CR32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/bmj.1.6077.1638","volume":"2","author":"RE Schneider","year":"1977","unstructured":"Schneider RE, Beeley L: Megaloblastic anemia associated with sulphasalazine treatment. Br Med J 2(6077):1638?1639, 1977","journal-title":"Br Med J"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/archinte.1980.00330190134047","volume":"140","author":"G Davies","year":"1980","unstructured":"Davies G, Palek J: Selective erythroid and megakaryocytic aplasia after sulfasalazine administration. Arch Intern Med 140:1122, 1980","journal-title":"Arch Intern Med"},{"key":"CR34","first-page":"2334","volume":"28","author":"A Nja","year":"1945","unstructured":"Nja A: Et tilfelle av agranulocytose etter behandling med salazopyrin. Nord Med 28:2334, 1945","journal-title":"Nord Med"},{"key":"CR35","first-page":"255","volume":"69","author":"CW Levy","year":"1949","unstructured":"Levy CW: Agranulocytose ved salazpyrinbruk. T Norsk Laegeforen 69:255, 1949","journal-title":"T Norsk Laegeforen"},{"issue":"Suppl","key":"CR36","first-page":"180","volume":"43","author":"P Koskinen","year":"1954","unstructured":"Koskinen P: Pancytopenia during salazopyrin treatment. A case report. Ann Chir Gynaecol Fenn (Suppl) 43:180?183, 1954","journal-title":"Ann Chir Gynaecol Fenn"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archinte.1958.00260140076012","volume":"101","author":"RS Evans","year":"1958","unstructured":"Evans RS, Ford WP: Studies of the bone marrow in immunological granulocytopenia following administration of salicylazosulfapyridine. Arch Intern Med 101:244?251, 1958","journal-title":"Arch Intern Med"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0016-5085(19)35345-4","volume":"37","author":"DA Roth","year":"1959","unstructured":"Roth DA, Lindert ME: A fatal case of azulfidine-induced agranulocytosis. Gastroenterology 37:787?789, 1959","journal-title":"Gastroenterology"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.1960.63020030002008a","volume":"172","author":"NO Ritz","year":"1960","unstructured":"Ritz NO, Fisher MJ: Agranulocytosis due to administration of salicylazosulfapyridine (azulfidine). JAMA 172:237?240, 1960","journal-title":"JAMA"},{"key":"CR40","first-page":"144","volume":"124","author":"HE Vinggard","year":"1962","unstructured":"Vinggard HE: Tre titfaelde of medikamental agranulocytose. Ogestr Laeg 124:144?146, 1962","journal-title":"Ogestr Laeg"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(63)92048-8","volume":"1","author":"JL Thirkettle","year":"1963","unstructured":"Thirkettle JL, Gough KR, Read AE: Agranulocytosis associated with sulphasalazine (salazopyrin) therapy. Lancet 1:1395?1397, 1963","journal-title":"Lancet"},{"key":"CR42","first-page":"270","volume":"20","author":"F Panitz","year":"1963","unstructured":"Panitz F: Agranulocytosis due to administration of salicylazosulfapyridine (azulfidine). Med Bull US Army Eur 20:270?271, 1963","journal-title":"Med Bull US Army Eur"},{"key":"CR43","first-page":"1220","volume":"61","author":"VE Darling","year":"1964","unstructured":"Darling VE: Drug agranulocytosis: A case study. Nurs Times 61:1220, 1964","journal-title":"Nurs Times"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/pgmj.49.575.669","volume":"49","author":"P Cochrane","year":"1973","unstructured":"Cochrane P, Atkins P, Ehsanullah S: Agranulocytosis associated with sulphasalazine therapy. Postgrad Med J 49:669?672, 1973","journal-title":"Postgrad Med J"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00007611-198005000-00011","volume":"73","author":"JL Maddocks","year":"1980","unstructured":"Maddocks JL, Slater DN: Toxic epidermal necrolysis, agranulocytosis and erythroid hyopplasia associated with sulphasalazine. J R Soc Med 73:587?588, 1980","journal-title":"J R Soc Med"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000202343","volume":"100","author":"LE Bottiger","year":"1963","unstructured":"Bottiger LE, Engstedt L, Lagercrantz R: The occurrence of Heinz-bodies during azulfidine treatment of ulcerative colitis. Gastroenterology 100:33?41, 1963","journal-title":"Gastroenterology"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000207777","volume":"59","author":"N Kaplinksy","year":"1978","unstructured":"Kaplinksy N, Frankel O: Salicylazosulphapyridine-induced Heinz-body anemia. Acta Haematol 59:310?314, 1978","journal-title":"Acta Haematol"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000198156","volume":"17","author":"RL Goodacre","year":"1978","unstructured":"Goodacre RL, Ali MAM, Vanderlinden B, Hamilton JD, Castelli M, Seaton T: Hemolytic anemia in patients receiving sulfasalazine. Digestion 17:503?508, 1978","journal-title":"Digestion"},{"key":"CR49","first-page":"501","volume":"70","author":"PA Hees Van","year":"1979","unstructured":"Van Hees PA, Van Elferen LW, Van Rossum JM, Van Tongeren JH: Hemolysis during salicylazosulfapyridine therapy. Am J Gastroenterol 70:501?505, 1979","journal-title":"Am J Gastroenterol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"570","DOI":"10.5694\/j.1326-5377.1976.tb140866.x","volume":"1","author":"TF Tydd","year":"1976","unstructured":"Tydd TF, Dyer NH: Sulphasalazine lung. Med J Aust 1:570?573, 1976","journal-title":"Med J Aust"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/thx.27.6.713","volume":"27","author":"ER Jones","year":"1972","unstructured":"Jones ER, Malone DNS: Sulphasalazine induced lung disease. Thorax 27:713?717, 1972","journal-title":"Thorax"},{"issue":"7881","key":"CR52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(74)91990-4","volume":"2","author":"M Eastwood","year":"1974","unstructured":"Eastwood M: Sulphasalazine-induced lung disease. Lancet 2(7881):659?660, 1974","journal-title":"Lancet"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/gut.15.3.185","volume":"15","author":"D Davies","year":"1974","unstructured":"Davies D, MacFarlane A: Fibrosing alveolitis and treatment with sulphasalazine. Gut 15:185?188, 1974","journal-title":"Gut"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2222.1974.tb01361.x","volume":"4","author":"P Thomas","year":"1974","unstructured":"Thomas P, Seaton A, Edwards J: Respiratory disease due to sulphasalazine. Clin Allergy 4:41?47, 1974","journal-title":"Clin Allergy"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1378\/chest.70.2.315","volume":"70","author":"K Constantinidis","year":"1976","unstructured":"Constantinidis K: Eosinophilic pneumonia: An unusual side effect of therapy with salicylazosulfapyridine. Chest 70:315?316, 1976","journal-title":"Chest"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000194205","volume":"39","author":"S Berliner","year":"1980","unstructured":"Berliner S, Neeman A, Shoenfeld Y, Eldar M, Rousso I, Kadish V, Pinkhas J: Salazopyrin-induced eosinophilic pneumonia. Respiration 39:119?120, 1980","journal-title":"Respiration"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1378\/chest.81.6.766","volume":"81","author":"T Williams","year":"1982","unstructured":"Williams T, Eidus L, Thomas P: Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy. Chest 81:766?768, 1982","journal-title":"Chest"},{"key":"CR58","doi-asserted-by":"crossref","unstructured":"Editorial: Sulphasalazine-induced lung disease. Lancet 2(879):504?505, 1974.","DOI":"10.1016\/S0140-6736(74)92026-1"},{"key":"CR59","first-page":"154","volume":"73","author":"OE Eade","year":"1980","unstructured":"Eade OE, Whorwell PJ, Smith CL, Alexander JR: Pulmonary function in patients with inflammatory bowel disease. Am J Gastroenterol 73:154?156, 1980","journal-title":"Am J Gastroenterol"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM196710122771503","volume":"277","author":"CA Dujovne","year":"1967","unstructured":"Dujovne CA, Chan CH, Zimmerman HJ: Sulfonamide hepatic injury. N Engl J Med 277:785?788, 1967","journal-title":"N Engl J Med"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM196601132740209","volume":"274","author":"J Fries","year":"1966","unstructured":"Fries J, Siraganian R: Sulfonamide hepatitis: Report of a case due to sulfamethaxazole and sulfisaxazole. N Engl J Med 274:95?97, 1966","journal-title":"N Engl J Med"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365521.1974.12096796","volume":"9","author":"M Tonder","year":"1974","unstructured":"Tonder M, Nordoy A, Elgio K: Sulfonamide-induced chronic liver disease. Scand J Gastroenterol 9:93?96, 1974","journal-title":"Scand J Gastroenterol"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-80-1-1","volume":"80","author":"WE Seaman","year":"1974","unstructured":"Seaman WE, Ishak KG, Plotz PH: Aspirin induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med 80:1?8, 1974","journal-title":"Ann Intern Med"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.1780190205","volume":"19","author":"WE Seaman","year":"1976","unstructured":"Seaman WE, Plotz PH: Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers. Arthritis Rheum 19:155?160, 1976","journal-title":"Arthritis Rheum"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.7326\/0003-4819-66-5-1052_2","volume":"66","author":"RE Randall","year":"1967","unstructured":"Randall RE: Renal failure following antibiotics. Ann Intern Med 66:1052?1053, 1967 (abstract)","journal-title":"Ann Intern Med"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/BF02239308","volume":"16","author":"CM Carvatti","year":"1971","unstructured":"Carvatti CM, Hooker TH: Acute massive hepatic necrosis with fatal liver failure. Am J Dig Dis 16:803?808, 1971","journal-title":"Am J Dig Dis"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.239.24.2590","volume":"239","author":"AA Mihas","year":"1978","unstructured":"Mihas AA, Goldenberg DJ, Slaughter RL: Sulfasalazine toxic reactions-hepatitis, fever, and skin rash with hypocomplementemia and immune complexes. JAMA 239:2590?2591, 1978","journal-title":"JAMA"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0016-5085(78)93771-X","volume":"75","author":"RP Sotolongo","year":"1978","unstructured":"Sotolongo RP, Neefe LI, Rudzki M, Ishak G: Hypersensitivity reactions to sulfasalazine with severe hepatotoxicity. Gastroenterology 75:95?99, 1978","journal-title":"Gastroenterology"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archinte.1978.03630320074025","volume":"138","author":"AC Chester","year":"1978","unstructured":"Chester AC, Diamond LH, Shreiner GE: Hypersensitivity to salicylazosulfapyridine-renal and hepatic toxic reactions. Arch Intern Med 138:1138?1139, 1978","journal-title":"Arch Intern Med"},{"key":"CR70","first-page":"561","volume":"72","author":"RM Gulley","year":"1979","unstructured":"Gulley RM, Mirza A, Kelley C: Hepatotoxicity of salicylazosulfapyridine: A case report and review of the literature. Am J Gastroenterol 72:561?564, 1979","journal-title":"Am J Gastroenterol"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/BF01072475","volume":"23","author":"RS Kanner","year":"1978","unstructured":"Kanner RS, Tedesco FJ, Kalser MA: Azulfidine-(sulfasalazine) induced hepatic injury. Am J Dig Dis 23:956?958, 1978","journal-title":"Am J Dig Dis"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF01255610","volume":"19","author":"R Rafoth","year":"1974","unstructured":"Rafoth R: Systemic granulomatous reaction to salicylazosulfapyridine in a patient with Crohn's disease. Am J Dig Dis 19:465?469, 1974","journal-title":"Am J Dig Dis"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/00007611-197809000-00031","volume":"71","author":"JP Callen","year":"1978","unstructured":"Callen JP, Soderstrom RM: Granulomatous hepatitis associated with salicylazosulfapyridine therapy. South Med J 71:1159?1160, 1978","journal-title":"South Med J"},{"issue":"2","key":"CR74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004836-198106000-00017","volume":"3","author":"A Namias","year":"1981","unstructured":"Namias A: Reversible sulphasalazine-induced granulomatous hepatitis. J Clin Gastroenterol 3(2):193?198, 1981","journal-title":"J Clin Gastroenterol"},{"key":"CR75","first-page":"1070","volume":"135","author":"SL Werlin","year":"1981","unstructured":"Werlin SL, Losek JD: Sulfasalazine hepatotoxicity. Am J Dis Child 135:1070?1071, 1981","journal-title":"Am J Dis Child"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1445-5994.1982.tb02433.x","volume":"12","author":"MD Smith","year":"1982","unstructured":"Smith MD, Gibson GE, Rowland R: Combined hepatotoxicity and neurotoxicity following sulphasalazine administration. Aust NZ J Med 12:76?80, 1982","journal-title":"Aust NZ J Med"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0016-5085(78)90125-7","volume":"75","author":"E Jacobs","year":"1978","unstructured":"Jacobs E, Pavlet P, Rahier J: Hypersensitivity reaction to sulfasalazine-another case. Gastroenterology 75:1193, 1978","journal-title":"Gastroenterology"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/gut.6.1.39","volume":"6","author":"D Alarcon-Segovia","year":"1965","unstructured":"Alarcon-Segovia D, Herskovic T, Dearing W, Bartholomew LG, Shorter RG: Lupus erythematosus cell phenomenon in patients with chronic ulcerative colitis. Gut 6:39?47, 1965","journal-title":"Gut"},{"issue":"6096","key":"CR79","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bmj.2.6096.1188","volume":"2","author":"MB Griffiths","year":"1977","unstructured":"Griffiths MB, Kane MA: Sulphasalazine-induced lupus syndrome in ulcerative colitis. Br Med J 2(6096):1188?1189, 1977","journal-title":"Br Med J"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1055\/s-0028-1129232","volume":"103","author":"BH Jaup","year":"1978","unstructured":"Jaup BH: Salosulfapyridin-induziertes lupus-erythematodes-syndrom bei colitis ulcerosa. Dtsch Med Wochenschr 103:1211?1213, 1978","journal-title":"Dtsch Med Wochenschr"},{"key":"CR81","first-page":"307","volume-title":"Clinics in Gastroenterology-Inflammatory Bowel Disease","author":"MK Basu","year":"1980","unstructured":"Basu MK, Asquith P: Oral manifestations of inflammatory bowel disease.In Clinics in Gastroenterology-Inflammatory Bowel Disease. RE Farmer (ed). London, WB Saunders, 1980, pp 307?321"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/014107688007300114","volume":"73","author":"AJ Crisp","year":"1980","unstructured":"Crisp AJ, Hoffbrand BI: Sulphasalazine-induced systemic lupus erythematosus in a patient with Sjogren's syndrome. J R Soc Med 73:60?61, 1980","journal-title":"J R Soc Med"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/pgmj.56.652.106","volume":"56","author":"J Reid","year":"1980","unstructured":"Reid J, Holt S, Housley E, Sneddon DJC: Raynaud's phenomenon induced by sulphasalazine. Postgrad Med J 56:106?107, 1980","journal-title":"Postgrad Med J"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/bmj.2.5523.1174","volume":"2","author":"AJ Cameron","year":"1966","unstructured":"Cameron AJ, Baron JH, Priestly BL: Erythema multiforme, drugs, and ulcerative colitis. Br Med J 2:1174?1178, 1966","journal-title":"Br Med J"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/inf.1969.1.issue-1.01","volume":"1","author":"J Strom","year":"1969","unstructured":"Strom J: Toxic epidermal necrolysis (Lyell's syndrome)?a report on four cases with three deaths. Scand J Infect Dis 1:209?216, 1969","journal-title":"Scand J Infect Dis"},{"issue":"8238","key":"CR86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(81)90332-9","volume":"2","author":"EJ Hensen","year":"1981","unstructured":"Hensen EJ, Claas FH, Vermeer BJ: Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis. Lancet 2(8238):151?152, 1981","journal-title":"Lancet"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.4.5628.452-b","volume":"4","author":"J Yelo","year":"1968","unstructured":"Yelo J, Shiel GD, Uldall PR: Unusual cause of yellow skin. Br Med J 4:452, 1968","journal-title":"Br Med J"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM197002122820710","volume":"282","author":"M Block","year":"1970","unstructured":"Block M, Genant H, Kirsner J: Pancreatitis as an adverse reaction to salicylazosulfapyridine. N Engl J Med 282:380?382, 1970","journal-title":"N Engl J Med"},{"issue":"3","key":"CR89","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-3476(78)80446-6","volume":"92","author":"S Werlin","year":"1978","unstructured":"Werlin S, Grand R: Bloody diarrhea?a new complication of sulfasalazine. J Pediatr 92(3):450?451, 1978","journal-title":"J Pediatr"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM198202183060708","volume":"306","author":"AG Schwartz","year":"1982","unstructured":"Schwartz AG, Targan S, Saxon A, Weinstein WM: Sulfasalazine-induced exacerbation of ulcerative colitis. N Engl J Med 306:409, 1982","journal-title":"N Engl J Med"},{"key":"CR91","first-page":"315","volume":"307","author":"RD Adler","year":"1982","unstructured":"Adler RD: Sulfasalazine-induced exacerbation of ulcerative colitis. N Engl J Med 307:315, 1982","journal-title":"N Engl J Med"},{"key":"CR92","first-page":"374","volume":"76","author":"BH Pokorney","year":"1981","unstructured":"Pokorney BH, Nichols TW: Pseudomembranous colitis. Am J Gastroenterology 76:374?376, 1981","journal-title":"Am J Gastroenterology"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0016-5085(73)80120-9","volume":"64","author":"J Franklin","year":"1973","unstructured":"Franklin J, Rosenberg I: Impaired folic acid absorption in inflammatory bowel disease: Effects of salicylazosulfapyridine (azulfidine). Gastroenterology 64:517?525, 1973","journal-title":"Gastroenterology"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.22.6.456","volume":"22","author":"C Swinson","year":"1981","unstructured":"Swinson C, Perry J, Lumb M, Levi AJ: Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis. Gut 22:456?461, 1981","journal-title":"Gut"},{"key":"CR95","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJM198112173052506","volume":"305","author":"CH Halsted","year":"1981","unstructured":"Halsted CH, Gandhi G, Tamura T: Sulfasalazine inhibits the absorbtion of folates in ulcerative colitis. N Engl J Med 305:1513?1514, 1981","journal-title":"N Engl J Med"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0015-0282(16)44000-8","volume":"31","author":"A Toth","year":"1979","unstructured":"Toth A: Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril 31:538?540, 1979","journal-title":"Fertil Steril"},{"issue":"8148","key":"CR97","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(79)92718-1","volume":"2","author":"A Toth","year":"1979","unstructured":"Toth A: Male infertility due to sulphasalazine. Lancet 2(8148):904, 1979","journal-title":"Lancet"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.22.6.452","volume":"22","author":"GG Birnie","year":"1981","unstructured":"Birnie GG, McLeod TIF, Watkinson G: Incidence of sulphasalazine-induced male infertility. Gut 22:452?455, 1981","journal-title":"Gut"},{"key":"CR99","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000198712","volume":"23","author":"JG Freeman","year":"1982","unstructured":"Freeman JG, Reece VAC, Venables CW: Sulphasalazine and spermatogenesis. Digestion 23:68?71, 1982","journal-title":"Digestion"},{"issue":"8137","key":"CR100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(79)90292-7","volume":"2","author":"AJ Levi","year":"1979","unstructured":"Levi AJ, Fisher AM, Hughes L, Hendry WF: Male infertility due to sulphasalazine. Lancet 2(8137):276?278, 1979","journal-title":"Lancet"},{"key":"CR101","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/gut.22.6.445","volume":"22","author":"S Toovey","year":"1981","unstructured":"Toovey S, Hudson E, Hendry WF, Levi AJ: Sulphasalazine and male infertility; reversibility and possible mechanism. Gut 22:445?451, 1981","journal-title":"Gut"},{"issue":"8140","key":"CR102","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(79)91512-5","volume":"2","author":"J Grieve","year":"1979","unstructured":"Grieve J: Male infertility due to sulphasalazine. Lancet 2(8140):464, 1979","journal-title":"Lancet"},{"issue":"8143","key":"CR103","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(79)91702-1","volume":"2","author":"AI Traub","year":"1979","unstructured":"Traub AI, Thompson W, Carville J: Male infertility due to sulphasalazine. Lancet 2(8143):639?640, 1979","journal-title":"Lancet"},{"key":"CR104","first-page":"441","volume":"74","author":"M Collen","year":"1980","unstructured":"Collen M: Azulfidine-induced oligospermia. Am J Gastroenterol 74:441?442, 1980","journal-title":"Am J Gastroenterol"},{"key":"CR105","first-page":"878A","volume":"70","author":"J Dhar","year":"1976","unstructured":"Dhar J, Selhub J, Rosenberg IH: Azulfidine inhibition of folic acid absorption: Confirmation of a specific saturable transport mechanism. Gastroenterology 70:878A, 1976","journal-title":"Gastroenterology"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0016-5085(19)31672-5","volume":"75","author":"P Sharon","year":"1978","unstructured":"Sharon P, Ligumsky M, Rachmilewitz D: Role of prostaglandins in ulcerative colitis: Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75:638?640, 1978","journal-title":"Gastroenterology"},{"key":"CR107","first-page":"1140","volume":"82","author":"CA O'Morain","year":"1982","unstructured":"O'Morain CA, Smethurst P, Hudson E, Levi AJ: Further studies on sulfasalazine induced male infertility. Gastroenterology 82:1140, 1982","journal-title":"Gastroenterology"},{"key":"CR108","first-page":"371","volume":"102","author":"BM Heiny","year":"1977","unstructured":"Heiny BM: Sinustachykardie neve nebenwiskung bei der therapie mit salazosulfapyridin. Dsch Med Wochenschr 102:371, 1977","journal-title":"Dsch Med Wochenschr"},{"key":"CR109","first-page":"1","volume":"33","author":"A Neeman","year":"1980","unstructured":"Neeman A, Berliner S, Shoenfeld Y, Kadish V, Pinkhas J: Salazopyrine-induced tachycardia. Biomedicine 33:1?2, 1980 (letter)","journal-title":"Biomedicine"},{"key":"CR110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.0954-6820.1940.tb09065.x","volume":"104","author":"N Svartz","year":"1940","unstructured":"Svartz N, Kallner S: Cyanosis in treatment with sulfonamide compounds. Acta Med Scand 104:309?312, 1940","journal-title":"Acta Med Scand"},{"key":"CR111","first-page":"1102","volume":"80","author":"A Attar","year":"1981","unstructured":"Attar A, Anuras S: Sulfasalazine and hair loss. Gastroenterology 80:1102, 1981 (abstract)","journal-title":"Gastroenterology"},{"key":"CR112","first-page":"850","volume":"204","author":"IW Wallace","year":"1970","unstructured":"Wallace IW: Neurotoxicity associated with a reaction to sulphasalazine. Practitioner 204:850?851, 1970","journal-title":"Practitioner"},{"key":"CR113","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3476(79)80786-6","volume":"95","author":"PD Goldstein","year":"1979","unstructured":"Goldstein PD, Alpers DH, Keating JP: Sulfapyridine metabolites in children with inflammatory bowel disease receiving sulfasalazine. J Pediatr 95:638?640, 1979","journal-title":"J Pediatr"},{"key":"CR114","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmj.282.6258.110","volume":"282","author":"CD Holdsworth","year":"1981","unstructured":"Holdsworth CD: Sulphasalazine desensitization. Br Med J 282:110, 1981","journal-title":"Br Med J"},{"key":"CR115","first-page":"1104","volume":"82","author":"BI Korelitz","year":"1982","unstructured":"Korelitz BI, Present DH, Rubin PH, Fochias SE: Desensitization to sulfasalazine in allergic patients with IBD: An important therapeutic modality. Gastroenterology 82:1104, 1982 (abstract)","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01296907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01296907\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01296907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T07:43:46Z","timestamp":1706082226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01296907"}},"subtitle":["Adverse effects and desensitization"],"short-title":[],"issued":{"date-parts":[[1983,9]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1983,9]]}},"alternative-id":["BF01296907"],"URL":"https:\/\/doi.org\/10.1007\/bf01296907","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,9]]}}}